Akoya Biosciences, Inc.

General ticker "AKYA" information:

  • Sector: Health Care
  • Industry: Life Sciences Tools & Services
  • Capitalization: $112.5M (TTM average)

Akoya Biosciences, Inc. follows the US Stock Market performance with the rate: 22.6%.

Estimated limits based on current volatility of 3.8%: low 1.23$, high 1.33$

Factors to consider:

  • North America accounted for 62.3% of revenue in the fiscal year ended 2024-12-31
  • Earnings for 3 months up through Q1 are below our estimates

Stock Forecast*

* forecast is subjective and experimental, should not be used for any investment decisions

Long term estimates were made for the period from 2024-12-31 to 2026-12-31

  • 2024-12-31 to 2025-12-31 estimated range: [1.33$, 4.06$]
  • 2025-12-31 to 2026-12-31 estimated range: [1.63$, 4.65$]

Financial Metrics affecting the AKYA estimates:

  • Negative: Non-GAAP EPS, $ of -0.97 <= 0.05
  • Positive: Interest expense per share, $ of 0.21 <= 0.68

Similar symbols

Short-term AKYA quotes

Long-term AKYA plot with estimates

Financial data

YTD 2022-12-31 2023-12-31 2024-12-31
Operating Revenue $74.86MM $96.63MM $81.67MM
Operating Expenses $140.97MM $154.30MM $128.40MM
Operating Income $-66.11MM $-57.67MM $-46.73MM
Non-Operating Income $-4.41MM $-5.62MM $-8.49MM
Interest Expense $4.55MM $8.76MM $10.43MM
R&D Expense $23.21MM $24.97MM $19.75MM
Income(Loss) $-70.52MM $-63.28MM $-55.22MM
Taxes $0.12MM $0.04MM $0.15MM
Profit(Loss)* $-70.64MM $-63.32MM $-55.37MM
Stockholders Equity $58.58MM $53.77MM $7.59MM
Inventory $14.49MM $17.88MM $24.32MM
Assets $176.03MM $180.37MM $125.00MM
Operating Cash Flow $-53.50MM $-50.90MM $-44.10MM
Capital expenditure $7.36MM $3.65MM $2.46MM
Investing Cash Flow $-14.08MM $3.35MM $-24.05MM
Financing Cash Flow $28.73MM $56.84MM $-3.21MM
Earnings Per Share** $-1.87 $-1.43 $-1.12

* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.